PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE

被引:920
作者
CARMELIET, P
SCHOONJANS, L
KIECKENS, L
REAM, B
DEGEN, J
BRONSON, R
DEVOS, R
VANDENOORD, JJ
COLLEN, D
MULLIGAN, RC
机构
[1] CATHOLIC UNIV LEUVEN, CTR MOLEC & VASC BIOL, B-3000 LOUVAIN, BELGIUM
[2] MIT, WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA
[3] MIT, DEPT BIOL, CAMBRIDGE, MA 02142 USA
[4] UNIV CINCINNATI, CHILDRENS HOSP RES FDN, CINCINNATI, OH 45229 USA
[5] TUFTS UNIV, SCH VET MED, BOSTON, MA 02111 USA
[6] CATHOLIC UNIV LEUVEN, HISTO & CYTOCHEM LAB, B-3000 LOUVAIN, BELGIUM
关键词
D O I
10.1038/368419a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Indirect evidence suggests a crucial role for the fibrinolytic system and its physiological triggers, tissue-type (t-PA) and urokinase-type (u-PA) plasminogen activator, in many proteolytic processes. Inactivation of the t-PA gene impairs clot lysis and inactivation of the u-PA gene results in occasional fibrin deposition. Mice with combined t-PA and u-PA deficiency suffer extensive spontaneous fibrin deposition, with its associated effects on growth, fertility and survival.
引用
收藏
页码:419 / 424
页数:6
相关论文
共 38 条
[1]   THE FIBRIN PLATE METHOD FOR ESTIMATING FIBRINOLYTIC ACTIVITY [J].
ASTRUP, T ;
MULLERTZ, S .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1952, 40 (02) :346-351
[2]  
ASTRUP T, 1987, PROGR CHEM FIBRINOLY, V3, P1
[3]  
BAKER MS, 1990, CANCER RES, V50, P4676
[4]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS [J].
BLASI, F ;
VASSALLI, JD ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :801-804
[5]  
BUSSO N, 1989, J BIOL CHEM, V264, P7455
[6]   MOUSE OVARIAN GRANULOSA-CELLS PRODUCE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, WHEREAS THE CORRESPONDING RAT-CELLS PRODUCE TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
CANIPARI, R ;
OCONNELL, ML ;
MEYER, G ;
STRICKLAND, S .
JOURNAL OF CELL BIOLOGY, 1987, 105 (02) :977-981
[7]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .2. EFFECTS ON HEMOSTASIS, THROMBOSIS, AND THROMBOLYSIS [J].
CARMELIET, P ;
STASSEN, JM ;
SCHOONJANS, L ;
REAM, B ;
VANDENOORD, JJ ;
DEMOL, M ;
MULLIGAN, RC ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2756-2760
[8]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .1. GENERATION BY HOMOLOGOUS RECOMBINATION AND CHARACTERIZATION [J].
CARMELIET, P ;
KIECKENS, L ;
SCHOONJANS, L ;
REAM, B ;
VANNUFFELEN, A ;
PRENDERGAST, G ;
COLE, M ;
BRONSON, R ;
COLLEN, D ;
MULLIGAN, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2746-2755
[9]  
COLLEN D, 1991, BLOOD, V78, P3114
[10]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266